Telemachus Therapeutics
Pittsburgh, US · Founded 2026
Find your way into Telemachus Therapeutics
Sign up to see every warm intro you have to Telemachus Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Telemachus Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MB
Michael BozikNamed on SEC filing
GH
Gregory HebrankNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$375K disclosed across 1 round · 2026
▶$375KraisedOct 2026 · 3 investors · PharmaceuticalsRule 506(b)
▶$375KraisedOct 2026 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael BozikExecutive Officer, Director, Promoter
- Gregory HebrankExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $375K
- Minimum investment
- $50K
- Proceeds to insiders
- $250K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Telemachus Therapeutics raised?
- Telemachus Therapeutics has disclosed $375K raised across 1 round.
- Where is Telemachus Therapeutics headquartered?
- Telemachus Therapeutics is headquartered in Pittsburgh, US.